News

The StrataQuest software was coupled with TissueFAXS, offering a convenient workflow that could automatically acquire up to ...
Truist analyst David MacDonald raised the firm’s price target on Quest Diagnostics (DGX) to $190 from $182 and keeps a Hold rating on the ...
Barclays raised the firm’s price target on Quest Diagnostics (DGX) to $185 from $175 and keeps an Equal Weight rating on the shares. The ...
A groundbreaking 'Declaration on Longevity and Precision Medicine' was launched at Abu Dhabi Global Health Week (ADGHW), ...